Why TXA and rFVIIa Are Not Equivalent in Trauma Bleeding Control – RPTH Journal
RPTH Journal shared on LinkedIn about a recent article by Bilgimol Chumappumkal Joseph et al, adding:
”Tranexamic acid vs recombinant FVIIa in severe trauma: same goal, very different outcomes
Both tranexamic acid (TxA) and recombinant activated factor VII (rhFVIIa) can reduce bleeding in severe trauma.
But do they carry the same risks?
A new study in RPTH Journal puts them head-to-head in a murine liver laceration model.
Key findings:
- Both rhFVIIa and TxA reduced blood loss compared with controls
- TXA normalised coagulation parameters and suppressed fibrinolysis effectively
- Survival at 7 days: ~80% with TxA vs ~50% with rhFVIIa
- rhFVIIa overcorrected coagulation, failed to suppress D-dimer, and exacerbated IL-6 formation
- Pulmonary fibrin deposition and microthrombi were observed exclusively in rhFVIIa-treated mice.”
Title: The effects of recombinant human activated factor VII and tranexamic acid on traumatic bleeding and mortality in mice
Authors: Bilgimol Chumappumkal Joseph, Juan Andres De Pablo-Moreno, Nicca Falah, Abraham Wentzel, Mia Lora Cacho, Eduardo Frias-Anaya, Miguel Lopez-Ramirez, Annette von Drygalski
Stay updated on all scientific advances with Hemostasis Today.
-
Apr 23, 2026, 04:08Suraj Mali: Pune Team Initiative for World Hemophilia Day 2026 Advances Early Diagnosis in Hemophilia
-
Apr 23, 2026, 03:58Adam Ho: What Does It Actually Mean to ”Prevent” a Stroke?
-
Apr 23, 2026, 03:49Jakob Krebs Christensen: Mobile Stroke Units Bring Imaging and Treatment Directly to the Patient
-
Apr 23, 2026, 03:30Kimberly Waddell: Mismatch in Post-Stroke Discharge Decisions Impacts Long-Term Recovery
-
Apr 23, 2026, 03:18Pablo Corral: Key Take‑Home Messages on Familial Hypercholesterolemia
-
Apr 23, 2026, 03:17Wolfgang Miesbach: The Haemophilia A Gene Therapy Story Is Moving from West to China
-
Apr 23, 2026, 02:17Francisco Chacón-Lozsán: Pulmonary Artery Catheter in Cardiogenic Shock From Obsolete Device to Modern Decision Tool
-
Apr 23, 2026, 01:33Maha Othman: Our Research Group Had a Highly Successful Showing at the ISLH 2026 Congress
-
Apr 22, 2026, 17:19Ralf Ludwig: Bridging Population Data and Immunology in Inflammatory Diseases